SEC Tracker
Get the app

Legend Biotech LEGN

Legend Biotech reports $51.7 million net income for Q3 2026.

Legend Biotech (LEGN) filed a 6-K with the SEC on Nov 10, 2026, 7:12 am ET. Source: the filing on SEC EDGAR.

Foreign issuer report

Form
6-K
Filed
Importance
Notable
  1. Net income of $51.7 million for the three months ended Sep 30, 2026.
  2. Total revenue of $359.5 million for the three months ended Sep 30, 2026.
  3. Operating income of $46.8 million for the three months ended Sep 30, 2026.
  4. Earnings per share of $0.13 for the three months ended Sep 30, 2026.

Written from the 6-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Legend Biotech files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.